A CASE OF OROMANDIBULAR DYSTONIA TREATED BY BOTULINUM TOXIN TYPE A AND DRY NEEDLING

被引：0

作者：

Diracoglu, Demirhan ^{[1
]}

Teksoz, Bahar ^{[1
]}

Karan, Ayse ^{[1
]}

Aksoy, Cihan ^{[1
]}

机构：

[1] Istanbul Univ, Tip Fak, Fiziksel Tip & Rehabil Anabilim Dali, Istanbul, Turkey

来源：

NOBEL MEDICUS | 2009年 / 5卷 / 01期

关键词：

Oromandibular dystonia; botulinum toxin type A; dry needling; MUSCLE AFFERENT BLOCK; TEMPOROMANDIBULAR-JOINT; DISLOCATION; DYSKINESIA;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Oromandibular dystonia (OMD) is a rare focal dystonia characterized by involuntary contraction Of masticatory and tongue muscles. Besides oral medication, local anesthetics and alcohol application, injection of botulinum toxin type A (BT-A) to the affected muscles may be used in the treatment of OMD. In this article, effects of combined treatment of BT-A injection and dry needling are discussed in a case of OMD with involuntary contraction in bilateral masseter and lateral pterygoid muscles who has not responded to any other treatment.

引用

页码：35 / 39

页数：5

共 50 条

[41] Biperiden/flupentixolTardive dystonia of the tongue treated with botulinum toxin A: case report
Reactions Weekly, 2008, 1219 (1) : 10 - 10
[42] AntipsychoticsCervical tardive dystonia, treated with botulinum toxin A: 2 case reports
Reactions Weekly, 2009, 1270 (1) : 6 - 6
[43] Exploring the Psychosocial Impact of Botulinum Toxin Type A Injections for Individuals With Oromandibular Dystonia: A Qualitative Study of Patients' Experiences
Page, Allyson D.
Elhayek, Nada
Baylor, Carolyn
Adams, Scott
Jog, Mandar
Yorkston, Kathryn
AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2021, 30 (03) : 1314 - 1328
[44] The quality-of-life impact of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia
Bhattacharyya, N
Tarsy, D
ANNALS OF NEUROLOGY, 2000, 48 (03) : 504 - 504
[45] Autonomic cardiovascular function in patients with cervical dystonia treated with botulinum toxin type A
Tiple, D.
Strano, S.
Colosimo, C.
Fabbrini, G.
Stivali, G.
Calcagnini, G.
Berardelli, A.
MOVEMENT DISORDERS, 2006, 21 : S381 - S381
[46] Clinical characterization of cranio-cervical dystonia treated with botulinum toxin type A
Maragoto, C
Mendoza, F
Alvarez, L
Morales, JM
Rodriguez, G
Alvarez, E
MOVEMENT DISORDERS, 2002, 17 : S280 - S281
[47] Botulinum toxin A in patients with oromandibular dystonia - Long-term follow-up
Tan, EK
Jankovic, J
NEUROLOGY, 1999, 53 (09) : 2102 - 2107
[48] Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin.
Laskawi, R
Rohrbach, S
LARYNGO-RHINO-OTOLOGIE, 2001, 80 (12): : 708 - 713
[49] Examining the Speech Intelligibility of Individuals With Oromandibular Dystonia Receiving Botulinum Toxin: A Series of Cases
Domingo, Ysabel
Page, Allyson D.
Adams, Scott G.
Jog, Mandar
CANADIAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY AND AUDIOLOGY, 2019, 43 (03): : 153 - 165
[50] Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A
Cardoso, F
ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 607 - 610

← 1 2 3 4 5 →